Ici efficacy information portal: a knowledgebase for responder prediction to immune checkpoint inhibitors

HIGHLIGHTS

SUMMARY

    Inhibiting CTLA-4 can result in the expansion of CD4+ effector T_cells, while inhibiting PD-1/PD-L1 can reinvigorate exhausted CD8+ T_cells. A series of additional ICI targets have also been investigated, such as the T_cell-expressed inhibitory receptors LAG-3, TIM-3 and TIGIT, and inhibitory ligands in the B7 family. In turn, the immunogenic micro-environment needs to permit proliferation of T_cells and their infiltration into the tumor. Conceptually, a high mutation burden could produce more neoantigens that can be processed and presented for T_cell recognition. The latest research makes use . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?